Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Memorial Sloan-Kettering Cancer Center
Research add new data to cancer vaccines body of knowledge
July 6th, 2005
New findings from the United States, United Kingdom and Switzerland describe advances in cancer vaccines. Study 1: Scientists compare antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn in a recent issue of Cancer Immunology Immunotherapy. According a study from the United States, "We have demonstrated previously that the optimal method for inducing an antibody response against defined cancer antigens is covalent conjugation of the antigen to keyhole limpet hemocyanin (KLH) and use of the potent saponin adjuvant QS-21. Single molecules of glycolipids (tetrasaccharides,...
Source: Biotech Week (2005-07-06)
|
